Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells.

Ma C, Fan R, Ahmad H, Shi Q, Comin-Anduix B, Chodon T, Koya RC, Liu CC, Kwong GA, Radu CG, Ribas A, Heath JR.

Nat Med. 2011 Jun;17(6):738-43. doi: 10.1038/nm.2375. Epub 2011 May 22.

2.

Concomitant detection of IFNα signature and activated monocyte/dendritic cell precursors in the peripheral blood of IFNα-treated subjects at early times after repeated local cytokine treatments.

Aricò E, Castiello L, Urbani F, Rizza P, Panelli MC, Wang E, Marincola FM, Belardelli F.

J Transl Med. 2011 May 17;9:67. doi: 10.1186/1479-5876-9-67.

3.

Early expression of stem cell-associated genes within the CD8 compartment after treatment with a tumor vaccine.

Kohler ME, Hallett WH, Chen QR, Khan J, Johnson BD, Orentas RJ.

Cell Immunol. 2010;265(1):65-73. doi: 10.1016/j.cellimm.2010.07.004. Epub 2010 Jul 17.

4.

A survey of current software for network analysis in molecular biology.

Thomas S, Bonchev D.

Hum Genomics. 2010 Jun;4(5):353-60. Review.

5.

Integrative platform to translate gene sets to networks.

Laakso M, Hautaniemi S.

Bioinformatics. 2010 Jul 15;26(14):1802-3. doi: 10.1093/bioinformatics/btq277. Epub 2010 May 27.

PMID:
20507894
6.

A phase I trial of immunotherapy with lapuleucel-T (APC8024) in patients with refractory metastatic tumors that express HER-2/neu.

Peethambaram PP, Melisko ME, Rinn KJ, Alberts SR, Provost NM, Jones LA, Sims RB, Lin LR, Frohlich MW, Park JW.

Clin Cancer Res. 2009 Sep 15;15(18):5937-44. doi: 10.1158/1078-0432.CCR-08-3282. Epub 2009 Sep 1.

7.

Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.

Worschech A, Chen N, Yu YA, Zhang Q, Pos Z, Weibel S, Raab V, Sabatino M, Monaco A, Liu H, Monsurró V, Buller RM, Stroncek DF, Wang E, Szalay AA, Marincola FM.

BMC Genomics. 2009 Jul 7;10:301. doi: 10.1186/1471-2164-10-301.

8.

Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-alpha.

Zimmerer JM, Lesinski GB, Ruppert AS, Radmacher MD, Noble C, Kendra K, Walker MJ, Carson WE 3rd.

Clin Cancer Res. 2008 Sep 15;14(18):5900-6. doi: 10.1158/1078-0432.CCR-08-0846.

9.

Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.

Critchley-Thorne RJ, Yan N, Nacu S, Weber J, Holmes SP, Lee PP.

PLoS Med. 2007 May;4(5):e176.

10.

Gene profiling for the prediction of tumor response to treatment: the case of immunotherapy.

Monsurrò V, Marincola FM.

Adv Exp Med Biol. 2007;593:86-94. Review. No abstract available.

PMID:
17265719
11.

Cancer immunotherapy: moving beyond current vaccines.

Rosenberg SA, Yang JC, Restifo NP.

Nat Med. 2004 Sep;10(9):909-15.

12.

Quiescent phenotype of tumor-specific CD8+ T cells following immunization.

Monsurrò V, Wang E, Yamano Y, Migueles SA, Panelli MC, Smith K, Nagorsen D, Connors M, Jacobson S, Marincola FM.

Blood. 2004 Oct 1;104(7):1970-8. Epub 2004 Jun 8.

13.

Active-specific immunization against melanoma: is the problem at the receiving end?

Monsurrò V, Wang E, Panelli MC, Nagorsen D, Jin P, Katia Z, Smith K, Ngalame Y, Even J, Marincola FM.

Semin Cancer Biol. 2003 Dec;13(6):473-80. Review.

PMID:
15001166
14.

Functional heterogeneity of vaccine-induced CD8(+) T cells.

Monsurrò V, Nagorsen D, Wang E, Provenzano M, Dudley ME, Rosenberg SA, Marincola FM.

J Immunol. 2002 Jun 1;168(11):5933-42.

15.

Frequency of MART-1/MelanA and gp100/PMel17-specific T cells in tumor metastases and cultured tumor-infiltrating lymphocytes.

Seiter S, Monsurro V, Nielsen MB, Wang E, Provenzano M, Wunderlich JR, Rosenberg SA, Marincola FM.

J Immunother. 2002 May-Jun;25(3):252-63.

16.

Kinetics of TCR use in response to repeated epitope-specific immunization.

Monsurrò V, Nielsen MB, Perez-Diez A, Dudley ME, Wang E, Rosenberg SA, Marincola FM.

J Immunol. 2001 May 1;166(9):5817-25.

17.

Status of activation of circulating vaccine-elicited CD8+ T cells.

Nielsen MB, Monsurro V, Migueles SA, Wang E, Perez-Diez A, Lee KH, Kammula U, Rosenberg SA, Marincola FM.

J Immunol. 2000 Aug 15;165(4):2287-96.

Supplemental Content

Support Center